Prostate tumor DCE-MRI data sets from 11 patients were shared among nine institutions, which determined AIFs using site-specific methods. The managing center performed pharmacokinetic data analysis using the Shutter-Speed model and these AIFs, and their scaled variants obtained with the reference-tissue method. Among the estimated parameters, Ktrans has the highest whereas τi has the lowest variability due to AIF uncertainty. The use of reference-tissue-adjusted AIFs reduces parameter variations. kep and τi are nearly insensitive to AIF scaling, suggesting that they may be robust imaging biomarkers in multicenter DCE-MRI trials where accurate and consistent AIF determination may be unattainable across sites.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords